The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Savinov, A. Y.
Right arrow Articles by Chervonsky, A. V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Savinov, A. Y.
Right arrow Articles by Chervonsky, A. V.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Substance via MeSH
Medline Plus Health Information
*Diabetes Type 1
The Journal of Immunology, 2001, 167: 6637-6643.
Copyright © 2001 by The American Association of Immunologists

IFN-{gamma} Affects Homing of Diabetogenic T Cells1

Alexei Y. Savinov*, F. Susan Wong{dagger} and Alexander V. Chervonsky2,*

* The Jackson Laboratory, Bar Harbor, ME 04609; and {dagger} Department of Pathology and Microbiology, School of Medical Sciences, University of Bristol, Bristol, United Kingdom

IFN-{gamma} is a cytokine with pleiotropic functions that participates in immune and autoimmune responses. The lack of IFN-{gamma} is known to delay the development of autoimmune diabetes in nonobese diabetic (NOD) mice. Splenocytes from diabetic NOD and IFN-{gamma} knockout (KO) NOD mice transfer diabetes into NOD recipients equally well. However, adoptive transfer of diabetogenic T cells from NOD mice into NOD.IFN-{gamma}-KO or NOD mice lacking {beta}-chain of IFN-{gamma} receptor (NOD.IFN-{gamma}R{beta}-KO) appeared to be much less efficient. We found that IFN-{gamma} influences the ability of diabetogenic cells to penetrate pancreatic islets. Tracing in vivo of insulin-specific CD8+ T cells has shown that homing of these cells to the islets of Langerhans was affected by the lack of IFN-{gamma}. While adhesion of insulin-specific CD8+ cells to microvasculature was normal, the diapedesis was significantly impaired. This effect was reversible by treatment of the animals with rIFN-{gamma}. Thus, IFN-{gamma} may, among other effects, influence immune and autoimmune responses by supporting the homing of activated T cells.




This article has been cited by other articles:


Home page
DiabetesHome page
Y.-H. Van, W.-H. Lee, S. Ortiz, M.-H. Lee, H.-J. Qin, and C.-P. Liu
All-trans Retinoic Acid Inhibits Type 1 Diabetes by T Regulatory (Treg)-Dependent Suppression of Interferon-{gamma}-Producing T-cells Without Affecting Th17 Cells
Diabetes, January 1, 2009; 58(1): 146 - 155.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
N. Solvason, Y.-P. Lou, W. Peters, E. Evans, J. Martinez, U. Ramirez, A. Ocampo, R. Yun, S. Ahmad, E. Liu, et al.
Improved Efficacy of a Tolerizing DNA Vaccine for Reversal of Hyperglycemia through Enhancement of Gene Expression and Localization to Intracellular Sites
J. Immunol., December 15, 2008; 181(12): 8298 - 8307.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Karumuthil-Melethil, N. Perez, R. Li, and C. Vasu
Induction of Innate Immune Response through TLR2 and Dectin 1 Prevents Type 1 Diabetes
J. Immunol., December 15, 2008; 181(12): 8323 - 8334.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
E. Sgouroudis, A. Albanese, and C. A. Piccirillo
Impact of Protective IL-2 Allelic Variants on CD4+Foxp3+ Regulatory T Cell Function In Situ and Resistance to Autoimmune Diabetes in NOD Mice
J. Immunol., November 1, 2008; 181(9): 6283 - 6292.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. B. J. Wong, R. Bos, and L. A. Sherman
Tumor-Specific CD4+ T Cells Render the Tumor Environment Permissive for Infiltration by Low-Avidity CD8+ T Cells
J. Immunol., March 1, 2008; 180(5): 3122 - 3131.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Y. Savinov, D. V. Rozanov, and A. Y. Strongin
Specific Inhibition of Autoimmune T Cell Transmigration Contributes to beta Cell Functionality and Insulin Synthesis in Non-obese Diabetic (NOD) Mice
J. Biol. Chem., November 2, 2007; 282(44): 32106 - 32111.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. J. Turner, E. Olivas, A. Gutierrez, G. Diaz, and P. C. Doherty
Disregulated Influenza A Virus-Specific CD8+ T Cell Homeostasis in the Absence of IFN-{gamma} Signaling
J. Immunol., June 15, 2007; 178(12): 7616 - 7622.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
A. Y. Savinov, D. V. Rozanov, and A. Y. Strongin
Mechanistic insights into targeting T cell membrane proteinase to promote islet {beta}-cell rejuvenation in type 1 diabetes
FASEB J, September 1, 2006; 20(11): 1793 - 1801.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Yu, G. C. Sharp, and H. Braley-Mullen
Thyrocytes Responding to IFN-{gamma} Are Essential for Development of Lymphocytic Spontaneous Autoimmune Thyroiditis and Inhibition of Thyrocyte Hyperplasia
J. Immunol., January 15, 2006; 176(2): 1259 - 1265.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
K. Chen, Y. Wei, A. Alter, G. C. Sharp, and H. Braley-Mullen
Chemokine expression during development of fibrosis versus resolution in a murine model of granulomatous experimental autoimmune thyroiditis
J. Leukoc. Biol., September 1, 2005; 78(3): 716 - 724.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Y. Savinov, D. V. Rozanov, V. S. Golubkov, F. S. Wong, and A. Y. Strongin
Inhibition of Membrane Type-1 Matrix Metalloproteinase by Cancer Drugs Interferes with the Homing of Diabetogenic T Cells into the Pancreas
J. Biol. Chem., July 29, 2005; 280(30): 27755 - 27758.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
A. Jorns, A. Gunther, H.-J. Hedrich, D. Wedekind, M. Tiedge, and S. Lenzen
Immune Cell Infiltration, Cytokine Expression, and {beta}-Cell Apoptosis During the Development of Type 1 Diabetes in the Spontaneously Diabetic LEW.1AR1/Ztm-iddm Rat
Diabetes, July 1, 2005; 54(7): 2041 - 2052.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
X. Zhang, M. C. Rodriguez-Galan, J. J. Subleski, J. R. Ortaldo, D. L. Hodge, J.-M. Wang, O. Shimozato, D. A. Reynolds, and H. A. Young
Peroxisome proliferator-activated receptor-{gamma} and its ligands attenuate biologic functions of human natural killer cells
Blood, November 15, 2004; 104(10): 3276 - 3284.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
N. Sarween, A. Chodos, C. Raykundalia, M. Khan, A. K. Abbas, and L. S. K. Walker
CD4+CD25+ Cells Controlling a Pathogenic CD4 Response Inhibit Cytokine Differentiation, CXCR-3 Expression, and Tissue Invasion
J. Immunol., September 1, 2004; 173(5): 2942 - 2951.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. M. W. Chong, Y. Chen, R. Darwiche, N. L. Dudek, W. Irawaty, P. Santamaria, J. Allison, T. W. H. Kay, and H. E. Thomas
Suppressor of Cytokine Signaling-1 Overexpression Protects Pancreatic {beta} Cells from CD8+ T Cell-Mediated Autoimmune Destruction
J. Immunol., May 1, 2004; 172(9): 5714 - 5721.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Trembleau, G. Penna, S. Gregori, N. Giarratana, and L. Adorini
IL-12 Administration Accelerates Autoimmune Diabetes in Both Wild-Type and IFN-{gamma}-Deficient Nonobese Diabetic Mice, Revealing Pathogenic and Protective Effects of IL-12-Induced IFN-{gamma}
J. Immunol., June 1, 2003; 170(11): 5491 - 5501.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
A. Y. Savinov, F. S. Wong, A. C. Stonebraker, and A. V. Chervonsky
Presentation of Antigen by Endothelial Cells and Chemoattraction Are Required for Homing of Insulin-specific CD8+ T Cells
J. Exp. Med., March 3, 2003; 197(5): 643 - 656.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
J. E. Greening, T. I.M. Tree, K. T. Kotowicz, A. G. van Halteren, B. O. Roep, N. J. Klein, and M. Peakman
Processing and Presentation of the Islet Autoantigen GAD by Vascular Endothelial Cells Promotes Transmigration of Autoreactive T-Cells
Diabetes, March 1, 2003; 52(3): 717 - 725.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
N. J. Hill, K. Van Gunst, and N. Sarvetnick
Th1 and Th2 Pancreatic Inflammation Differentially Affects Homing of Islet-Reactive CD4 Cells in Nonobese Diabetic Mice
J. Immunol., February 15, 2003; 170(4): 1649 - 1658.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
A. Y. Savinov, A. Tcherepanov, E. A. Green, R. A. Flavell, and A. V. Chervonsky
Contribution of Fas to diabetes development
PNAS, January 21, 2003; 100(2): 628 - 632.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
J. Yang, A. Reutzel-Selke, C. Steier, A. Jurisch, S. G. Tullius, B. Sawitzki, J. Kolls, H.-D. Volk, and T. Ritter
Targeting of Macrophage Activity by Adenovirus-Mediated Intragraft Overexpression of TNFRp55-Ig, IL-12p40, and vIL-10 Ameliorates Adenovirus-Mediated Chronic Graft Injury, whereas Stimulation of Macrophages by Overexpression of IFN-{gamma} Accelerates Chronic Graft Injury in a Rat Renal Allograft Model
J. Am. Soc. Nephrol., January 1, 2003; 14(1): 214 - 225.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
L. S. K. Walker, L. J. Ausubel, A. Chodos, N. Bekarian, and A. K. Abbas
CTLA-4 Differentially Regulates T Cell Responses to Endogenous Tissue Protein Versus Exogenous Immunogen
J. Immunol., December 1, 2002; 169(11): 6202 - 6209.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Yu, G. C. Sharp, and H. Braley-Mullen
Dual Roles for IFN-{gamma}, But Not for IL-4, in Spontaneous Autoimmune Thyroiditis in NOD.H-2h4 Mice
J. Immunol., October 1, 2002; 169(7): 3999 - 4007.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2001 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2001 by The American Association of Immunologists, Inc. All rights reserved.